Related Experiment Video

Updated: Mar 15, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.8K

Combination strategies to enhance the potency of monocyte-derived dendritic cell-based cancer vaccines

Ronald J Fecek1, Walter J Storkus1,2,3,4,5

  • 1Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Immunotherapy
|September 9, 2016
PubMed

Insights

Dendritic cell (DC) cancer vaccines show promise. Combining them with agents that normalize the tumor microenvironment (TME) may boost anti-tumor immunity and improve treatment effectiveness.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Dendritic cells (DCs) are key inducers of adaptive immunity.
  • The clinical application of DC-based cancer vaccines is under active investigation.
  • Monotherapy cancer vaccines have shown limited clinical success.

Purpose of the Study:

  • To explore novel therapeutic strategies combining DC-based cancer vaccines with immune-normalizing agents.
  • To enhance the efficacy of DC cancer vaccines by targeting the tumor microenvironment (TME).

Main Methods:

  • Investigating combination vaccine strategies.
  • Developing agents to antagonize immunosuppressive networks in the TME.
  • Exploring methods to condition the TME for improved T cell function.

Main Results:

  • Combination vaccines aim to overcome TME-mediated immunosuppression.
  • Strategies focus on facilitating T cell recruitment, function, and durability.
  • Enhanced clinical potency of DC-based cancer vaccine platforms is anticipated.

Conclusions:

  • Combining DC cancer vaccines with TME-modulating agents is a promising strategy.
  • This approach is expected to significantly improve anti-tumor immune responses.
  • Novel combination regimens hold potential for more effective cancer therapies.
Keywords:
cancercombination immunotherapydendritic cellimmunoconditioningimmunoregulationtargeted therapyvaccine

More Related Videos

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

12.2K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K